FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Prostate Cancer Drug Gets Fast Track

FDA grants Lantheus Holdings and Point Biopharma Global a fast track designation for 177Lu-PNT2002 for treating metastatic castration resistant prosta...

latest-news-card-1
Human Drugs

Medtronics MiniMed 780G Gets FDA Approval

After a delay caused by an FDA 2021 inspection and Warning Letter, the agency approves Medtronics MiniMed 780G insulin pump.

latest-news-card-1
Biologics

bluebird bio BLA for Sickle Cell Gene Therapy

bluebird bio files for priority review a BLA for lovotibeglogene autotemcel (lovo-cel), a gene therapy for patients with sickle cell disease.

latest-news-card-1
Human Drugs

Generic Group Questions Guide on Guidance Meetings

Generic drug lobbying arm says FDAs draft guidance entitled Product-Specific Guidance (PSG) Meetings Between FDA and ANDA Applicants Under GDUFA does ...

latest-news-card-1
Human Drugs

Foghorn Therapeutics Hit with Partial Clinical Hold

FDA places a partial clinical hold on a Foghorn Therapeutics clinical study of FHD-609 in synovial sarcoma and SMARCB1-deleted tumors after the compan...

Medical Devices

FDA Clear Maxtecs Oxygen Monitor

FDA clears a Maxtec 510(k) for the MaxO2 ME+p, an oxygen monitor with integrated pressure monitoring intended for continuous patient monitoring.

latest-news-card-1
Medical Devices

Avanos Medical Recalls Respiratory Suction Device

Avanos Medical recalls its Avanos Ballard Access Closed Suction System with Y-Manifold or Elbow Manifold after receiving complaints about cracked mani...

latest-news-card-1
Human Drugs

FDA Extends Review of Daiichi Leukemia NDA

FDA extends by three months its review of a Daiichi Sankyo NDA resubmisson for quizartinib in combination with chemotherapy for treating adult patien...

latest-news-card-1
Human Drugs

CDER Denies Bausch Petition on Duobrii ANDAs

CDER denies a 2021 citizen petition from Bausch Health that urged FDA not to approve any ANDA that cites Duobrii as the reference-listed drug unless t...

latest-news-card-1
Human Drugs

Novartis Gets Another Facility OKd for Pluvicto

FDA approves Novartis Radioligand Therapy manufacturing facility in Millburn, NJ to manufacture prostate cancer therapy Pluvicto, which has been in sh...